POSTTRANSCRIPTIONAL MODIFICATION OF SERUM CREATINE-KINASE IN INFECTED INTENSIVE-CARE PATIENTS

被引:7
作者
DELANGHE, JR
DEBUYZERE, ML
DESCHEERDER, IK
VANROSTENBERGHE, HL
FAUST, U
RODENBACH, JM
KRUSEJARRES, JD
WIEME, RJ
机构
[1] UNIV STUTTGART,INST BIOMED TECH,W-7000 STUTTGART 80,GERMANY
[2] KATHARINEN HOSP,INST KLIN CHEM,W-7000 STUTTGART 1,GERMANY
关键词
Activation energy; Bacteremia; Carboxypeptidase N; Creatine kinase; Intensive care;
D O I
10.1016/0009-8981(90)90337-R
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Low creatine kinase (CK) activities in serum are associated with high fatality rates in intensive care patients. The underlying mechanisms for this phenomenon were investigated. No correlation was found with other biochemical markers of inflammation (CRP, alpha-1 acid glycoprotein, alpha-2 macroglobulin). In the patients' serum a factor is described which is capable of increasing the activation energy of normal CK-MM, indicating molecular changes in CK-structure. This factor is likely to be an enzyme which is present in liver tissue and in fibroblasts. Similar results were obtained after in vitro treatment of normal serum samples with arylsulfatase. Furthermore, bacterial strains isolated in the serum of intensive care patients were found to alter human CK structure. In the investigated patient group, changes in CK activation energy are influenced by serum factors other than carboxypeptidase N activity. © 1990.
引用
收藏
页码:115 / 124
页数:10
相关论文
共 24 条
  • [1] CAVANAGH KT, 1987, CLIN CHEM, V33, P1306
  • [2] CHAPELLE JP, 1980, CLIN CHEM, V26, P457
  • [3] DELANGHE J, 1987, European Journal of Clinical Investigation, V17, pA17
  • [4] DELANGHE J, 1987, Annals of Clinical Biochemistry, V24, P106
  • [5] DELANGHE J, 1986, CLIN CHEM, V34, P713
  • [6] DUBOIS G, 1979, 7TH M INT SOC NEUR J, P306
  • [7] DEVELOPMENT OF CARBOXYPEPTIDASE K (CREATINE-KINASE CONVERSION FACTOR) IN MAN
    EDWARDS, RJ
    WATTS, DC
    [J]. CLINICA CHIMICA ACTA, 1987, 162 (01) : 69 - 74
  • [8] ELDIN ES, 1986, J CLIN CHEM CLIN BIO, V24, P283
  • [9] FRITZ H, 1984, SELECTED TOPICS CLIN, V2, P305
  • [10] HAGELAUER U, 1983, J CLIN CHEM CLIN BIO, V21, P874